Momenta Pharmaceuticals Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Momenta Pharmaceuticals Inc.

MNTA 52.48

0.0%

Oct 2 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: idos who wrote (2871)	10/25/2011 12:31:26 PM
From: DewDiligence_on_SI	of 3027

There’s some convoluted argumentation in this thread, IMO. My own opinion is that the AG launch will have a small effect, if any, on the probability that the Judge issues a PI. By directing MNTA to produce a Memorandum of Law (i.e. a precedent) in support of MNTA’s interpretation of one of its patent claims (which must be submitted to the Court today), the Judge signaled that MNTA already met the irreparable harm threshold for a PI. Thus, the remaining issue of consequence in the PI calculus is the likelihood of MNTA’s prevailing in a patent trial on the merits, and SNY’s AG launch has no bearing whatsoever on that.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next